Chikungunya Fever - Pipeline Review, H2 2017

  • ID: 4419029
  • Report
  • 103 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Abivax SA
  • Ennaid Therapeutics LLC
  • Hawaii Biotech Inc
  • Integral Molecular Inc
  • Mymetics Corp
  • PaxVax Inc
  • MORE
Chikungunya Fever - Pipeline Review, H2 2017

Summary

The latest Pharmaceutical and Healthcare disease pipeline guide Chikungunya Fever - Pipeline Review, H2 2017, provides an overview of the Chikungunya Fever (Infectious Disease) pipeline landscape.

Chikungunya is a viral disease transmitted to humans by the bite of infected Aedes aegypti mosquitoes. Chikungunya virus (CHIKV) is a member of the genus Alpha virus, in the family Togaviridae. Symptoms of Chikungunya includes debilitating arthralgia (joint pain), swelling of joints, stiffness of joints, myalgia (muscular pain), headache, fatigue (weakness), nausea, vomiting and rash and fever. Treatment includes use of NSAIDs.

Report Highlights

The latest Pharmaceutical and Healthcare latest pipeline guide Chikungunya Fever - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Chikungunya Fever (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Chikungunya Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chikungunya Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 2, 6, 14 and 8 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 8 and 5 molecules, respectively.

Chikungunya Fever (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Chikungunya Fever (Infectious Disease).
  • The pipeline guide reviews pipeline therapeutics for Chikungunya Fever (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Chikungunya Fever (Infectious Disease) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Chikungunya Fever (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Chikungunya Fever (Infectious Disease)
Reasons to Buy:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Chikungunya Fever (Infectious Disease).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Chikungunya Fever (Infectious Disease) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abivax SA
  • Ennaid Therapeutics LLC
  • Hawaii Biotech Inc
  • Integral Molecular Inc
  • Mymetics Corp
  • PaxVax Inc
  • MORE
Introduction

Chikungunya Fever - Overview

Chikungunya Fever - Therapeutics Development

Pipeline Overview

Pipeline by Companies

Pipeline by Universities/Institutes

Products under Development by Companies

Products under Development by Universities/Institutes

Chikungunya Fever - Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Chikungunya Fever - Companies Involved in Therapeutics Development

Abivax SA

Arno Therapeutics Inc

Bharat Biotech International Ltd

Ennaid Therapeutics LLC

Etubics Corp

Hawaii Biotech Inc

Indian Immunologicals Ltd

Inovio Pharmaceuticals Inc

Integral Molecular Inc

Integrated BioTherapeutics Inc

Moderna Therapeutics Inc

Mymetics Corp

Nanotherapeutics Inc

Paradigm Biopharmaceuticals Ltd

PaxVax Inc

Profectus BioSciences Inc

Shionogi & Co Ltd

Takeda Pharmaceutical Co Ltd

Themis Bioscience GmbH

Valneva SE

Vaxart Inc

Chikungunya Fever - Drug Profiles

(chikungunya + Zika) (bivalent) vaccine - Drug Profile

ABX-311 - Drug Profile

AR-12 - Drug Profile

BBV-87 - Drug Profile

chikungunya (viral like particles) vaccine - Drug Profile

chikungunya (virus like particle) vaccine - Drug Profile

chikungunya vaccine - Drug Profile

chikungunya vaccine - Drug Profile

chikungunya vaccine - Drug Profile

chikungunya vaccine - Drug Profile

chikungunya vaccine - Drug Profile

chikungunya vaccine - Drug Profile

chikungunya vaccine - Drug Profile

chikungunya vaccine - Drug Profile

chikungunya vaccine - Drug Profile

chikungunya vaccine - Drug Profile

chikungunya vaccine - Drug Profile

chikungunya vaccine - Drug Profile

chikungunya vaccine - Drug Profile

chikungunya vaccine - Drug Profile

Gene Therapy for Chikungunya - Drug Profile

HSRx-431 - Drug Profile

IMCKV-063 - Drug Profile

Monoclonal Antibodies for Chikungunya - Drug Profile

Monoclonal Antibodies for Equine Encephalitis and Chikungunya - Drug Profile

Monoclonal Antibodies to Inhibit CHIKV E2 for Chikungunya - Drug Profile

mRNA-1388 - Drug Profile

MV-CHIK - Drug Profile

pentosan polysulfate sodium - Drug Profile

Peptides for Infectious Diseases - Drug Profile

SCV-305 - Drug Profile

Small Molecule to Inhibit NS2 and NS3 for Chikungunya - Drug Profile

Small Molecule to Inhibit NS4 for Chikungunya Fever - Drug Profile

Small Molecules for Chikungunya - Drug Profile

Small Molecules for Chikungunya - Drug Profile

Small Molecules for Chikungunya Fever - Drug Profile

Small Molecules for Chikungunya Fever - Drug Profile

Small Molecules for Infectious Disease - Drug Profile

SVIR-001 - Drug Profile

Synthetic Peptides for Chikungunya - Drug Profile

TAK-507 - Drug Profile

Tatbeclin-1 - Drug Profile

VLA-1553 - Drug Profile

Chikungunya Fever - Dormant Projects

Chikungunya Fever - Product Development Milestones

Featured News & Press Releases

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Number of Products under Development for Chikungunya Fever, H2

Number of Products under Development by Companies, H2

Number of Products under Development by Universities/Institutes, H2

Products under Development by Companies, H2

Products under Development by Universities/Institutes, H2

Number of Products by Stage and Target, H2

Number of Products by Stage and Mechanism of Action, H2

Number of Products by Stage and Route of Administration, H2

Number of Products by Stage and Molecule Type, H2

Chikungunya Fever - Pipeline by Abivax SA, H2

Chikungunya Fever - Pipeline by Arno Therapeutics Inc, H2

Chikungunya Fever - Pipeline by Bharat Biotech International Ltd, H2

Chikungunya Fever - Pipeline by Ennaid Therapeutics LLC, H2

Chikungunya Fever - Pipeline by Etubics Corp, H2

Chikungunya Fever - Pipeline by Hawaii Biotech Inc, H2

Chikungunya Fever - Pipeline by Indian Immunologicals Ltd, H2

Chikungunya Fever - Pipeline by Inovio Pharmaceuticals Inc, H2

Chikungunya Fever - Pipeline by Integral Molecular Inc, H2

Chikungunya Fever - Pipeline by Integrated BioTherapeutics Inc, H2

Chikungunya Fever - Pipeline by Moderna Therapeutics Inc, H2

Chikungunya Fever - Pipeline by Mymetics Corp, H2

Chikungunya Fever - Pipeline by Nanotherapeutics Inc, H2

Chikungunya Fever - Pipeline by Paradigm Biopharmaceuticals Ltd, H2

Chikungunya Fever - Pipeline by PaxVax Inc, H2

Chikungunya Fever - Pipeline by Profectus BioSciences Inc, H2

Chikungunya Fever - Pipeline by Shionogi & Co Ltd, H2

Chikungunya Fever - Pipeline by Takeda Pharmaceutical Co Ltd, H2

Chikungunya Fever - Pipeline by Themis Bioscience GmbH, H2

Chikungunya Fever - Pipeline by Valneva SE, H2

Chikungunya Fever - Pipeline by Vaxart Inc, H2

Chikungunya Fever - Dormant Projects, H2

List of Figures

Number of Products under Development for Chikungunya Fever, H2

Number of Products under Development by Companies, H2

Number of Products under Development by Universities/Institutes, H2

Number of Products by Top 10 Targets, H2

Number of Products by Stage and Top 10 Targets, H2

Number of Products by Top 10 Mechanism of Actions, H2

Number of Products by Stage and Top 10 Mechanism of Actions, H2

Number of Products by Routes of Administration, H2

Number of Products by Stage and Routes of Administration, H2

Number of Products by Top 10 Molecule Types, H2

Number of Products by Stage and Top 10 Molecule Types, H
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abivax SA
  • Arno Therapeutics Inc
  • Bharat Biotech International Ltd
  • Ennaid Therapeutics LLC
  • Etubics Corp
  • Hawaii Biotech Inc
  • Indian Immunologicals Ltd
  • Inovio Pharmaceuticals Inc
  • Integral Molecular Inc
  • Integrated BioTherapeutics Inc
  • Moderna Therapeutics Inc
  • Mymetics Corp
  • Nanotherapeutics Inc
  • Paradigm Biopharmaceuticals Ltd
  • PaxVax Inc
  • Profectus BioSciences Inc
  • Shionogi & Co Ltd
  • Takeda Pharmaceutical Co Ltd
  • Themis Bioscience GmbH
  • Valneva SE
  • Vaxart Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll